Prediction of nipple involvement in breast cancer after neoadjuvant chemotherapy: Should we rely on breast MRI to preserve the nipple?
- PMID: 37490171
- DOI: 10.1007/s10549-023-07041-8
Prediction of nipple involvement in breast cancer after neoadjuvant chemotherapy: Should we rely on breast MRI to preserve the nipple?
Abstract
Background: Indications for nipple sparing mastectomy (NSM) is extending to post-neoadjuvant chemotherapy (NAC) setting. Eligibility for NSM with an optimum tumor-nipple distance (TND) after NAC is unclear. We examined predictive factors for nipple tumor involvement in patients undergoing total mastectomy following NAC.
Methods: Clinical and pathological data from prospectively collected medical records of women with invasive breast carcinoma, who were undergone NAC and total mastectomy with sentinel lymph node biopsy and/or axillary lymph node dissection were analyzed. PreNAC and postNAC magnetic resonance imaging (MRI) views were examined and a cut-off TND value for predicting the negative nipple tumor status was determined.
Results: Among 180 women, the final mastectomy specimen analysis revealed that 12 (7%) had nipple involvement as invasive carcinoma. Patients with nipple involvement had more postNAC multifocal/multicentric tumors (p: 0.03), larger tumors on preNAC and postNAC images (p: 0.002 and p < 0.001), shorter median TNDs on preNAC and postNAC images (7 mm-IQR 1.5-14, p: 0.005 and 8.5 mm-IQR 3-15.5, p < 0.001, respectively), more nipple retraction on preNAC and postNAC images (p: 0.007 and p: 0.006) and more nipple areola complex skin thickening (> 2mm) on preNAC and postNAC images (p < 0.001 and p: 0.01). The best likelihood ratios (LR) belonged to the postNAC positivity of the < 20 mm TND, with a + LR of 3.40, and - LR of 0.11 for nipple involvement. PreNAC positivity of the < 20 mm TND also had a similar - LR of 0.14.
Conclusion: A TND-cut-off ≥ 2 cm on preNAC and postNAC MRI was shown to be highly predictive of negative nipple tumor involvement.
Keywords: Breast cancer; Breast magnetic resonance imaging; Neoadjuvant chemotherapy; Nipple involvement.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Rubens RD, Sexton S, Tong D, Winter PJ, Knight RK, Hayward JL (1980) Combined chemotherapy and radiotherapy for locally advanced breast cancer. Eur J Cancer 16(3):351–356. https://doi.org/10.1016/0014-2964(80)90352-7 - DOI
-
- Wolmark N, Fau WJ, Fau ME, Bryant J, Fisher B (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National surgical adjuvant breast and bowel project B-18. J Natl Cancer Inst Monogr. https://doi.org/10.1093/oxfordjournals.jncimonographs.a003469 - DOI - PubMed
-
- Bartholomew AJ, Dervishaj OA, Sosin M, Kerivan LT, Tung SS, Caragacianu DL et al (2019) Neoadjuvant chemotherapy and nipple-sparing mastectomy: timing and postoperative complications. Ann Surg Oncol 26(9):2768–2772. https://doi.org/10.1245/s10434-019-07418-4 - DOI - PubMed
-
- Headon HL, Kasem A, Mokbel K (2016) The oncological safety of nipple-sparing mastectomy: a systematic review of the literature with a pooled analysis of 12,358 procedures. Arch Plast Surg 43(4):328–338. https://doi.org/10.5999/aps.2016.43.4.328 - DOI - PubMed - PMC
-
- Burdge EC, Yuen J, Hardee M, Gadgil PV, Das C, Henry-Tillman R et al (2013) Nipple skin-sparing mastectomy is feasible for advanced disease. Ann Surg Oncol 20(10):3294–3302. https://doi.org/10.1245/s10434-013-3174-4 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
